---
schema_version: "secwatch.filing_event.v1"
accession: "0001096906-23-000901"
form_type: "8-K"
ticker: "UTMD"
cik: "0000706698"
company_name: "UTAH MEDICAL PRODUCTS INC"
filed_at: "2023-04-25T23:59:59+00:00"
generated_at: "2026-06-16T17:22:13.255752+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# UTMD Q1 2023: NI +19.2% to $4.2M, EPS $1.16; OUS sales +23%; cash $80.9M

## Summary
- Consolidated sales $12.5M, up 1.6% YoY; OUS sales up 23% (28% constant currency), domestic down 10%.
- Operating income margin 35.5% (down from 36.7%) due to $348K higher litigation expenses.
- Net income $4.2M, EPS $1.16 vs $0.96; NI margin 33.7% vs 28.7%.
- Cash and investments $80.9M, up $5.9M from Dec 31, 2022; no debt.
- Management reaffirms FY2023 objectives; regular quarterly dividend $0.295/share paid in Q1.

## SEC filing metadata
- accession: 0001096906-23-000901
- form_type: 8-K
- ticker: UTMD
- cik: 0000706698
- company_name: UTAH MEDICAL PRODUCTS INC
- filed_at: 2023-04-25T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01, 99.1
- EDGAR index: https://www.sec.gov/Archives/edgar/data/706698/000109690623000901/0001096906-23-000901-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/706698/000109690623000901/utmd-20230425.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001096906-23-000901
- JSON: https://secwatch.observer/filing/0001096906-23-000901.json
- Plain text: https://secwatch.observer/filing/0001096906-23-000901.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.